GSA CAPITAL PARTNERS LLP - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 95 filers reported holding ATHIRA PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$600
-41.3%
297,052
-14.3%
0.05%
-50.0%
Q2 2023$1,022
+13.4%
346,431
-3.8%
0.10%
+14.6%
Q1 2023$901
+4.9%
360,242
+32.9%
0.09%
-16.8%
Q4 2022$859
-99.8%
270,989
+59.9%
0.11%
+59.7%
Q3 2022$503,000169,5180.07%
Other shareholders
ATHIRA PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Logos Global Management LP 1,630,744$21,249,0002.19%
VR Adviser, LLC 1,000,000$13,030,0001.78%
ACUTA CAPITAL PARTNERS, LLC 310,030$4,040,0001.70%
Ikarian Capital, LLC 860,000$11,207,0001.67%
Bristlecone Advisors, LLC 761,563$9,923,0001.19%
Perceptive Advisors 6,851,832$89,280,0000.69%
DAFNA Capital Management LLC 160,983$2,098,0000.53%
PATHSTONE FAMILY OFFICE, LLC 1,442,247$18,792,0000.47%
Potomac Capital Management, Inc. 40,000$521,0000.46%
RTW INVESTMENTS, LP 1,906,557$24,842,0000.36%
View complete list of ATHIRA PHARMA INC shareholders